News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Beiersdorf AG Owner Unwilling To Sell To Procter & Gamble, Source Says
September 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, Sept 29 (Reuters) - German Beiersdorf's (BEIG.DE) majority shareholder maxingvest is not willing to sell its stake to Procter & Gamble, a person familiar with the situation said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
GLP-1
Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal
February 24, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
February 24, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition
February 23, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Novartis Bets Up to $1.7B in Cardio-Focused Peptide Partnership
February 19, 2026
·
2 min read
·
Tristan Manalac
